ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

LAWRENCE LERNER MD

427 GUY PARK AVE - PRIMARY & SPECIALTY CARE DEPT. ST. MARY'S HOSPITAL @ AMSTERDAM

Amsterdam | New York | 12010

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2013

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,634Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 131

$403K Total Retail Price of All Prescriptions

Rank: 40 out of 131

242 Patients Receiving at Least One Drug in Part D
98%* Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in New York
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

5% of this provider’s 242 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 242 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $70 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in New York
FUROSEMIDE 882 877* 97 1 4
METOPROLOL TARTRATE 499 494* 73 2 8
POTASSIUM CHLORIDE 411 411 39 3 27
LEVOTHYROXINE SODIUM 408 403* 61 4 3
NAMENDA 381 381 24 5 20
AMLODIPINE BESYLATE 267 267 33 6 2
LISINOPRIL 251 251 35 7 6
WARFARIN SODIUM 223 206 33 8 10
OXYBUTYNIN CHLORIDE ER 201 196* 23 9 133
SERTRALINE HCL 196 196 28 10 24
DONEPEZIL HCL 191 191 24 11 22
MIRTAZAPINE 178 178 29 12 35
GABAPENTIN 169 169 24 13 19
ATORVASTATIN CALCIUM 164 159* 26 14 7
SIMVASTATIN 145 140* 33 15 1
ALENDRONATE SODIUM 126 126 16 16 36
TRAZODONE HCL 122 117* 25 17 44
QUETIAPINE FUMARATE 122 117* 19 A 17 30
ESCITALOPRAM OXALATE 115 110* 20 19 56
CITALOPRAM HBR 115 110* 18 19 31
ALBUTEROL SULFATE 113 108* 26 21 73
CLOPIDOGREL 112 112 17 22 13
METOPROLOL SUCCINATE 112 112 19 22 11
TAMSULOSIN HCL 110 105* 20 24 25
ISOSORBIDE MONONITRATE ER 104 104 13 25 57
CARBIDOPA-LEVODOPA 103 103 17 26 84
OLANZAPINE 88 <11 <11 A 27 89
ATENOLOL 77 <11 <11 28 21
LEVETIRACETAM 76 71* 13 29 41
ALLOPURINOL 75 75 11 30 41
METFORMIN HCL 74 <11 <11 31 9
DIGOX 74 69* 14 31 88
GLIPIZIDE 71 <11 <11 33 66
LATANOPROST 68 <11 <11 34 192
DIOVAN 68 <11 <11 34 29
NOVOLOG FLEXPEN 67 <11 <11 36 135
LOSARTAN POTASSIUM 67 <11 <11 36 15
PREDNISONE 64 64 13 38 49
METOCLOPRAMIDE HCL 61 <11 <11 39 158
ACETIC ACID 60 <11 <11 40 281
PAROXETINE HCL 58 <11 <11 41 82
DILTIAZEM 24HR CD 58 <11 <11 41 222
HYDROCHLOROTHIAZIDE 55 <11 <11 43 12
BENZTROPINE MESYLATE 54 <11 <11 R 44 114
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.